Genitourinary Cancers Symposium Annual Meeting Coverage

AUA 2017, holep laser, green laser beam, laser, urology, nephrology

Photodynamic Therapy Shows Benefit in BCG-Unresponsive NMIBC

By

Jody A. Charnow

February 21, 2023

Investigators reported 90- and 450-day complete response rates of 53% and 28%, respectively, according to interim results from a phase 2 trial.

Patients diagnosed with MIBC are at a significant risk for death — which has not greatly improved in

Genitourinary Cancers Symposium

Neoadjuvant Pembrolizumab Shows Promise for Cisplatin-Ineligible MIBC

By

Natasha Persaud

February 21, 2023

There is an unmet need for systemic treatment options in patients with muscle-invasive bladder cancer who are ineligible for cisplatin-based neoadjuvant chemotherapy, according to investigators.

Genitourinary Cancers Symposium

Neoadjuvant Chemo Predicts Better Survival in Node Positive UTUC

By

Natasha Persaud

February 21, 2023

Receipt of neoadjuvant vs adjuvant chemotherapy did not differ significantly by clinical nodal stage.

ESRD and Treatments May Raise Cancer Risk

Genitourinary Cancers Symposium

Neoadjuvant Chemotherapy-Induced AKI Tied With Worse MIBC Outcomes

By

Natasha Persaud

February 21, 2023

Acute kidney injury frequently occurs during neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer.

Genitourinary Cancers Symposium

Systemic Therapy Does Not Worsen Cytoreductive Nephrectomy Outcomes

By

Natasha Persaud

February 21, 2023

Management of metastatic renal cell carcinoma should be highly individualized, according to investigators.

Sometimes the distinctions between cancer treatment groups are a little blurry. Here’s a guide to their definitions and origins.

Genitourinary Cancers Symposium

Survival Improving in De Novo mHSPC Cases

By

Jody A. Charnow

February 17, 2023

In the VHA system, use of doublet therapy increased to more than 50% of mHSPC cases since 2020.

Group of men of different races in a warehouse

Genitourinary Cancers Symposium

Survival Edge Found Among Black US Veterans With mCRPC

By

Jody A. Charnow

February 17, 2023

New study corroborates findings from a prior study of men receiving care in the Veterans Health Administration system.

Genitourinary Cancers Symposium

Prostate Cancer Surgery vs SBRT Outcomes Reported

By

Jody A. Charnow

February 17, 2023

As far as investigators are aware, their study is the first randomized controlled trial comparing radical prostatectomy and stereotactic body radiation therapy.